Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 110

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 110
---
 Mr.Ronen Twito, who is also nominated to be Executive Chairman of the board of directors of the combined company, Prof. Michel Revel, Mr.Olivier Samuel, Mr.Eran Iohan, Ms. Liora Oren, Ms. Tammy Galili and Mr.Alexander Zwyer. At each annual ordinary shareholders’ meeting of the combined company, the term of office of all directors serving at that time shall end and new directors shall be elected, by a resolution adopted by a Simple Majority. Directors whose term of office has ended as aforesaid may be re -electedfor an additional term. The board of directors may, by a resolution adopted by the board of directors, appoint an additional director or directors to the company, either to fill a position that has become vacant for any reason or as an additional director or directors, provided that the number of directors does not exceed six. Any vacancy, however created (whether by resignation, departure or otherwise, and/or otherwise with respect to any available position of office in case that the number of directors then in office is less than six (6)), shall continue until the next annual ordinary shareholders’ meeting. Subject to the provisions of Swiss law, the board of directors may delegate its powers to the committees of the board of directors, to its CEO, to an officer in the combined company, or to another person. The delegation of authority may be for a specific matter or for a specific period of time, all at the discretion of the board of directors. 16 Further, NLS is a foreign private issuer and, as such, is eligible for an exemption from certain Nasdaq corporate governance requirements that apply to issuers that are not foreign private issuers. A discussion of any material differences in the corporate laws of Israel and Switzerland please see the section entitled “ The Merger Agreement — Governance of the Combined Company after the Merger.” Share Ownership of NLS Directors and Executive Officers As of August28, 2025, NLS’s directors and executive officers as a group, owned and were entitled to vote 502,101 NLS Common Shares, or 12.1% of the outstanding NLS Common Shares. The directors and executive officers have informed us that they intend to vote all of their NLS Common Shares “FOR”the approval of the Merger. Share Ownership of Kadimastem Directors and Executive Officers As of August28, 2025, Kadimastem’s directors and executive officers as a group, owned and were entitled to vote